Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A3CMGM5
Thu, 15.05.2025
APONTIS PHARMA AG
APONTIS PHARMA publishes results for the first quarter of 2025 and confirms forecast for 2025
Group sales rise to EUR 12.9 million in Q1 2025 (3M 2024: EUR 10.0 million)
Single Pill combinations grew strongly overall by EUR 0.6 million. The portfolio more than compensated for the tender-related decline of EUR 1.0 million at Tonotec.
Further im [ … ]
Mon, 31.03.2025
APONTIS PHARMA AG
APONTIS PHARMA with significant sales and earnings increase in 2024 financial year – squeeze-out and merger planned
Sales increases significantly to EUR 48.5 million in 2024 financial year (2023: EUR 37.0 million)
Strong increase in Single Pill combination revenues to EUR 34.4 million (2023: EUR 25.6 million)
EBITDA increases by EUR 16.8 mill [ … ]
Wed, 05.03.2025
APONTIS PHARMA AG
Publication of inside information pursuant to Article 17 of the Regulation (EU) No. 596/2014APONTIS PHARMA AG: Zentiva AG submits formal request to carry out a merger squeeze-out of the minority shareholders of APONTIS PHARMA AG – merger agreement planned
Monheim / Rhein, 5 March 2025. Zentiva AG today submitted a formal request to APONTIS PHARMA [ … ]